UY29256A1 - Uso de deirvados de acido ciclopropanoico sustituidos para producir medicamentos para tratar el síndrome metabólico - Google Patents
Uso de deirvados de acido ciclopropanoico sustituidos para producir medicamentos para tratar el síndrome metabólicoInfo
- Publication number
- UY29256A1 UY29256A1 UY29256A UY29256A UY29256A1 UY 29256 A1 UY29256 A1 UY 29256A1 UY 29256 A UY29256 A UY 29256A UY 29256 A UY29256 A UY 29256A UY 29256 A1 UY29256 A1 UY 29256A1
- Authority
- UY
- Uruguay
- Prior art keywords
- metabolic syndrome
- replaced
- acid substituted
- treat metabolic
- cyclopropanoic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere al uso de derivados de ácido ciclopropanoico sustituidos y a sus sales fisiológicamente toleradas para producir medicamentos para el tratamiento del síncrome metabólico. Se describe el uso de los compuestos de fórmula I, en la que los radicales tienen los significados indicados, y sales fisiológicamente tolerables de los mismos, para producir un medicamento para el tratamiento del síndrome metabólico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004060041A DE102004060041A1 (de) | 2004-12-14 | 2004-12-14 | Verwendung von substituierten Cyclopropansäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms |
DE102005039245 | 2005-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29256A1 true UY29256A1 (es) | 2006-07-31 |
Family
ID=35945136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29256A UY29256A1 (es) | 2004-12-14 | 2005-12-20 | Uso de deirvados de acido ciclopropanoico sustituidos para producir medicamentos para tratar el síndrome metabólico |
Country Status (20)
Country | Link |
---|---|
US (2) | US20080045590A1 (es) |
EP (1) | EP1827415B1 (es) |
JP (1) | JP2008523122A (es) |
KR (1) | KR20070086194A (es) |
AR (1) | AR052265A1 (es) |
AT (1) | ATE455543T1 (es) |
AU (1) | AU2005315975A1 (es) |
BR (1) | BRPI0519064A2 (es) |
CA (1) | CA2590024A1 (es) |
DE (1) | DE502005008929D1 (es) |
IL (1) | IL183464A0 (es) |
MA (1) | MA29131B1 (es) |
MX (1) | MX2007006798A (es) |
MY (1) | MY138165A (es) |
NO (1) | NO20073031L (es) |
NZ (1) | NZ555155A (es) |
RU (1) | RU2007126842A (es) |
TW (1) | TW200635575A (es) |
UY (1) | UY29256A1 (es) |
WO (1) | WO2006063681A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8053867B2 (en) * | 2008-08-20 | 2011-11-08 | Honeywell International Inc. | Phosphorous-comprising dopants and methods for forming phosphorous-doped regions in semiconductor substrates using phosphorous-comprising dopants |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1361875A2 (en) * | 2001-02-16 | 2003-11-19 | Aventis Pharmaceuticals Inc. | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
CA2470591A1 (en) * | 2001-12-20 | 2003-07-03 | Merck & Co., Inc. | Therapeutic compounds for treating dyslipidemic conditions |
PE20030701A1 (es) * | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
-
2005
- 2005-11-30 RU RU2007126842/15A patent/RU2007126842A/ru not_active Application Discontinuation
- 2005-11-30 EP EP05814551A patent/EP1827415B1/de active Active
- 2005-11-30 CA CA002590024A patent/CA2590024A1/en not_active Abandoned
- 2005-11-30 BR BRPI0519064-9A patent/BRPI0519064A2/pt not_active IP Right Cessation
- 2005-11-30 WO PCT/EP2005/012763 patent/WO2006063681A1/de active Application Filing
- 2005-11-30 NZ NZ555155A patent/NZ555155A/en not_active IP Right Cessation
- 2005-11-30 AT AT05814551T patent/ATE455543T1/de not_active IP Right Cessation
- 2005-11-30 AU AU2005315975A patent/AU2005315975A1/en not_active Abandoned
- 2005-11-30 MX MX2007006798A patent/MX2007006798A/es not_active Application Discontinuation
- 2005-11-30 KR KR1020077013437A patent/KR20070086194A/ko not_active Application Discontinuation
- 2005-11-30 DE DE502005008929T patent/DE502005008929D1/de active Active
- 2005-11-30 JP JP2007545874A patent/JP2008523122A/ja not_active Abandoned
- 2005-12-12 TW TW094143771A patent/TW200635575A/zh unknown
- 2005-12-12 AR ARP050105191A patent/AR052265A1/es not_active Application Discontinuation
- 2005-12-13 MY MYPI20055838A patent/MY138165A/en unknown
- 2005-12-20 UY UY29256A patent/UY29256A1/es unknown
-
2007
- 2007-05-28 IL IL183464A patent/IL183464A0/en unknown
- 2007-06-07 US US11/759,510 patent/US20080045590A1/en not_active Abandoned
- 2007-06-12 MA MA29989A patent/MA29131B1/fr unknown
- 2007-06-14 NO NO20073031A patent/NO20073031L/no not_active Application Discontinuation
-
2008
- 2008-12-04 US US12/328,052 patent/US8222240B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO20073031L (no) | 2007-08-03 |
RU2007126842A (ru) | 2009-01-27 |
MY138165A (en) | 2009-04-30 |
MA29131B1 (fr) | 2008-01-02 |
DE502005008929D1 (de) | 2010-03-11 |
EP1827415A1 (de) | 2007-09-05 |
IL183464A0 (en) | 2007-10-31 |
BRPI0519064A2 (pt) | 2008-12-23 |
WO2006063681A1 (de) | 2006-06-22 |
ATE455543T1 (de) | 2010-02-15 |
TW200635575A (en) | 2006-10-16 |
US20090088474A1 (en) | 2009-04-02 |
NZ555155A (en) | 2009-09-25 |
US20080045590A1 (en) | 2008-02-21 |
EP1827415B1 (de) | 2010-01-20 |
CA2590024A1 (en) | 2006-06-22 |
JP2008523122A (ja) | 2008-07-03 |
AU2005315975A1 (en) | 2006-06-22 |
MX2007006798A (es) | 2007-08-07 |
US8222240B2 (en) | 2012-07-17 |
AR052265A1 (es) | 2007-03-07 |
KR20070086194A (ko) | 2007-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30871A1 (es) | Uso derivados de acido de piranona sustituidos para producir medicamentos para tratar el sindrome metabolico. | |
NI201200184A (es) | Morfolinopirimidinas y su uso en terapia | |
UY28732A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico, procesos para su preparación y su uso como medicamentos. | |
ECSP088747A (es) | Pirazoles como inhibidores de la 11-beta-hsd1 | |
SV2004001691A (es) | Nuevos derivados de fluoroglicosidos aromaticos, medicamentos que contienen compuestos y sus usos | |
CL2011000589A1 (es) | Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer. | |
DOP2011000218A (es) | Derivados de sulfonamida | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
CR11641A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
SV2010003451A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
UY31918A (es) | Compuestos de pirazol inhibidores de fgfr, composiciones farmaceuticas que los comprenden, procesos para su preparacion y su uso como medicamento | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
UY28726A1 (es) | N-ciclohexilimidazolinonas sustituidas.procedimientos para su preparación y su uso como medicamentos. | |
AR079208A2 (es) | Inhibidores de la actividad de proteina tirosina quinasa, composicion y uso de dichos inhibidores para la preparacion de un medicamento para tratar una enfermedad, trastorno o condicion oftalmica | |
AR079945A1 (es) | Derivados de pirazina como inhibidores de glucogeno sintasa quinasa 3 (gsk3) | |
UY31885A (es) | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. | |
EA201070588A1 (ru) | Производные 1,2,3-триазола для применения в качестве ингибиторов стеароил-соа десатуразы | |
AR078613A1 (es) | Derivados de sulfoxidos benzooxazolicos y benzotriazolicos inhibidores de autotaxinas, medicamentos que los contienen y uso de los mismos para el tratamiento de tumores. | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
UY31968A (es) | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos | |
CL2011001413A1 (es) | Compuestos derivados de 5-amino-2-(1-hidroxi-etil)-tetrahidropirano; composicion farmaceutica que comprende a uno de los compuestos; y su uso en la preparacion de medicamentos para la prevencion o el tratamiento de una infeccion bacteriana. | |
UY31141A1 (es) | Compuestos de piperidina y sus usos | |
CR11825A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo |